All advertisements and commercially sponsored publications are independent from editorial decisions. Farname does not endorse any product or service marked as an advertisement or promoted by a sponsor in Farname publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
Farname reserves the right to decline any type of advertising that damages the brand of Farname or is inappropriate to the content held on the Farname network.
Farname will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).
Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher request its removal.
Farname will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).
All advertisements for drug-specific campaigns must comply with the relevant Iranian legislation that regulates advertising. Advertisers should make available to Farname the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, the full generic name of each active ingredient should appear. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
All advertisements for drug specific campaigns should encourage correct and rational use and must not be misleading.
Advertisements and editorial content must be clearly distinguishable. Farname will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
If any advert is requested outside of Farname standard advertising positions then a request should be made to editorial who will respond with a full and final decision within two business days.
Information about complaints concerning advertisements will be included in the Advertisements page.
We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you. To learn more about this “behavioral advertising” practice or to opt-out of this use of your anonymous information, you can visit here
Please send any complaints about advertising to: info@farname.ir
